These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23278714)

  • 21. Tuberculosis screening prior to anti-tumor necrosis factor therapy among patients with immune-mediated inflammatory diseases in Japan: a longitudinal study using a large-scale health insurance claims database.
    Tomio J; Yamana H; Matsui H; Yamashita H; Yoshiyama T; Yasunaga H
    Int J Rheum Dis; 2017 Nov; 20(11):1674-1683. PubMed ID: 29076252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can ELISpot replace the tuberculin skin test for latent tuberculosis?
    Greveson K
    Br J Nurs; 2009 Nov 12-25; 18(20):1248-54. PubMed ID: 20081663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
    Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
    Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil.
    Amorim RF; Viegas ERC; Carneiro AJV; Esberard BC; Chinem ES; Correa RS; Rodrigues L; Ribeiro-Alves M; Silva KS; de Souza HS; Carvalho ATP
    Dig Dis Sci; 2019 Jul; 64(7):1916-1922. PubMed ID: 30673986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 'either test positive' strategy for latent tuberculous infection before anti-tumour necrosis factor treatment.
    Jung YJ; Lee JY; Jo KW; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):428-34. PubMed ID: 24670697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment.
    Jung YJ; Lyu J; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1300-6. PubMed ID: 22863375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of an IFN-gamma assay in the diagnosis of latent tuberculosis in patients with psoriasis in a highly endemic setting.
    de Andrade Lima E; de Andrade Lima M; de Lorena VM; de Miranda Gomes Y; Lupi O; Benard G
    Acta Derm Venereol; 2011 Oct; 91(6):694-7. PubMed ID: 21629971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.
    Sauzullo I; Mengoni F; Scrivo R; Valesini G; Potenza C; Skroza N; Marocco R; Lichtner M; Vullo V; Mastroianni CM
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):834-40. PubMed ID: 20550765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis.
    Latorre I; Carrascosa JM; Vilavella M; Díaz J; Prat C; Domínguez J; Ferrándiz C
    J Infect; 2014 Dec; 69(6):600-6. PubMed ID: 25148944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
    Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
    J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
    Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
    Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay.
    Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A
    Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay.
    Matulis G; Jüni P; Villiger PM; Gadola SD
    Ann Rheum Dis; 2008 Jan; 67(1):84-90. PubMed ID: 17644549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers.
    Saraceno R; Specchio F; Chiricozzi A; Sarmati L; Amicosante M; Chimenti MS; Chimenti S
    Expert Opin Biol Ther; 2014 Feb; 14(2):151-6. PubMed ID: 24303977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report.
    Malaviya AN; Kapoor S; Garg S; Rawat R; Shankar S; Nagpal S; Khanna D; Furst DE
    J Rheumatol; 2009 Jul; 36(7):1414-20. PubMed ID: 19487263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-γ release assay in patients considered for anti-tumor necrosis factor-α therapy.
    Casas S; Andreu A; Juanola X; Bordas X; Alcaide F; Moure R; Anibarro L; Cuchí E; Esteve M; Ortiz V; Guerra MR; Rodríguez J; Reina D; Salvador G; Guardiola J; Surís X; Pascual MA; Martí C; Martínez-Lacasa X; Cuquet J; Gonzalez L; Santin M
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):57-65. PubMed ID: 21851871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculin skin test and interferon-γ release assay show better correlation after the tuberculin 'window period' in tuberculosis contacts.
    Anibarro L; Trigo M; Villaverde C; Pena A; González-Fernández A
    Scand J Infect Dis; 2011 Jul; 43(6-7):424-9. PubMed ID: 21332285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.
    Hadaya K; Bridevaux PO; Roux-Lombard P; Delort A; Saudan P; Martin PY; Janssens JP
    Transplantation; 2013 Jun; 95(12):1485-90. PubMed ID: 23694948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.